Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PNT

POINT Biopharma Global (PNT) Stock Price, News & Analysis

POINT Biopharma Global logo

About POINT Biopharma Global Stock (NASDAQ:PNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$12.45
$14.23
52-Week Range
N/A
Volume
3.29 million shs
Average Volume
1.44 million shs
Market Capitalization
$1.33 billion
P/E Ratio
13.89
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for POINT Biopharma Global and its competitors with MarketBeat's FREE daily newsletter.

PNT Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Lilly Completes Acquisition of POINT Biopharma
See More Headlines

PNT Stock Analysis - Frequently Asked Questions

POINT Biopharma Global Inc. (NASDAQ:PNT) posted its quarterly earnings data on Monday, November, 13th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.07. The company had revenue of $2.79 million for the quarter, compared to the consensus estimate of $8 million. POINT Biopharma Global had a trailing twelve-month return on equity of 21.10% and a net margin of 39.62%.

Based on aggregate information from My MarketBeat watchlists, some other companies that POINT Biopharma Global investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Disc Medicine (IRON), Arista Networks (ANET), e.l.f. Beauty (ELF) and Builders FirstSource (BLDR).

Company Calendar

Last Earnings
11/13/2023
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PNT
Fax
N/A
Employees
129
Year Founded
N/A

Profitability

Trailing P/E Ratio
13.89
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$98.29 million
Pretax Margin
52.16%

Debt

Sales & Book Value

Annual Sales
$226.58 million
Price / Cash Flow
13.31
Book Value
$4.68 per share
Price / Book
N/A

Miscellaneous

Free Float
89,518,000
Market Cap
$1.33 billion
Optionable
Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:PNT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners